Search
Botanix is a medical dermatology company.

Botanix in $15m raising

Medical dermatology company Botanix Pharmaceuticals has raised $15 million through a strongly supported share placement, with the proceeds set to be spent on developing its lead product for acne.

Login

(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

Share Price

Closing price for the last 90 trading days
Source: Morningstar

Top 10 Shareholders

Substantial shareholders as published in the annual report.
Source: Morningstar

Total Shareholder Return as at 30/09/19

1 year TSR5 year TSR
12thPharmAust373%-3%
40thBotanix Pharmaceuticals159%44%
385thBauMart Holdings-2%
568thHotCopper Holdings-32%
733 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar

Share Transactions

18/07/19
$0 Issued
27/04/18
$19k Bought
27/04/18
$94k Sold
Total value as at the date of the transaction
Source: Morningstar

Revenue

94th↑Botanix Pharmaceuticals$4.7m
95th↑BauMart Holdings$4.6m
97th↑PharmAust$4.4m
98th↑HotCopper Holdings$4.3m
197 listed industrial companies ranked by revenue.
Source: Morningstar

BNiQ Disclaimer